HLA-A*0201 | B2M | PRAME (SLLQHLIGL)

Product Inquiry

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
SoziniberceptOPT-302; VGX-300Phase 3 ClinicalOrphan Europe SarlNeovascularization, Pathologic; Retinal Diseases; Diabetic macular oedema; Retinal Degeneration; Eye Diseases; Macular Degeneration
Details
EG-016EG-016; Ad-VEGF-APhase 2 ClinicalArk Therapeutics LtdPeripheral Vascular Diseases
Details
EG-011EG-011; Ad-VEGF-DPhase 2 ClinicalArk Therapeutics LtdAngina Pectoris
Details
  • Product Inquiry
  • Clinical Drug Information
Contact Us

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8